Please login to the form below
drug treatment
This page shows the latest drug treatment news and features for those working in and with pharma, biotech and healthcare.
UK biotech Synairgen treats first patient in phase 3 COVID-19 trial
UK biotech company Synairgen has treated the first patient in a phase 3 trial evaluating its potential COVID-19 treatment SNG001. ... Prior to the COVID-19 pandemic, Synairgen had been evaluating the drug as a treatment for COPD and asthma, although its
Latest news
-
Roche gets EU approval for fixed-dose Herceptin/Perjeta combination
It also addresses the increasing demand across healthcare systems for faster and more flexible treatment solutions,” he added. ... Herceptin has been hit by biosimilar competition, with much of the market share taken from Roche’s drug treatment by
-
Abivax’s COVID-19 study declared Research National Priority by French government
Drug treatment is being investigated in high-risk COVID-19 patients. Abivax’s COVID-19 study evaluating its anti-inflammatory candidate ABX464 has been deemed a ‘research national priority’ by a ... AGE trial with ABX464 drug candidate a research
-
UK selects Shionogi’s Fetcroja for antimicrobial reimbursement scheme
Prior to the launch of Shionogi's Fetcroja (cefiderocol) in the UK, the drug had already gained European Commission approval earlier this year, and it is the first treatment which protects ... In the US, Shionogi’s drug is approved under the name
-
Novo Nordisk launches late-stage study in Alzheimer’s disease
The study will investigate and evaluate the efficacy and safety of once-daily oral semaglutide compared to placebo in Alzheimer’s, with an expected main treatment period in the trials of ... disease.”. Alzheimer’s is a notoriously difficult therapy
-
Lilly picks up gene therapy programme in $1bn Prevail Therapeutics acquisition deal
Within Prevail’s clinical pipeline, PR001 has already scored a US Food and Drug Administration (FDA) fast-track designation for the treatment of PD-GBA patients and nGD. ... It has also been granted an FDA orphan drug designation for the treatment of
More from news
Approximately 0 fully matching, plus 918 partially matching documents found.
Latest Intelligence
-
Time to tear down the wallpaper?
treatment or breakthrough drug?
-
AI: the smart money is on the smart thinking
This influx of capital means there are already close to 200 start-ups using AI in drug discovery. ... Take, for example, the case of baricitinib, originally an Eli Lilly rheumatoid arthritis drug, now repurposed as a promising treatment for COVID-19.
-
AI and genomics: a revolution in drug discovery and development
Other purposes. The approach can be applied later in the drug development process. ... Gardner concluded: “Many pharmaceutical companies are looking at repurposing: does an approved drug have potential as a treatment for a new condition?
-
As COVID-19 takes over the world, biopharma fights back
An experimental antiviral: Gilead’s remdesivir. Gilead’s remdesivir, an experimental antiviral drug, is arguably the most-talked about potential treatment for COVID-19. ... The combination drug was first included in Chinese health authorities’
-
Pharma funding and M&A in 2020
But just as Big Tech has disrupted plenty of other industries, there is every reason to think that it will be interested in the opportunities to move more into drug therapy ... a cool $63bn (which was also notable for putting the world’s best-selling
More from intelligence
Approximately 0 fully matching, plus 47 partially matching documents found.
Latest appointments
-
Finland's Faron Pharmaceuticals appoints new medical director
In his new role he will join Turku-based Faron's executive management team and oversee its drug development strategy, including its clinical programmes for Traumakine and Clevegen. ... Our lead drug candidate Traumakine, for the treatment of Acute
-
Canbex hires former Lilly medical director
As chief medical officer at Canbex Dr Lledó will lead preparations for proof of concept trials for the company's lead candidate VSN16R, an oral drug intended for the treatment of ... As a practicing neurologist and experienced drug developer, I am very
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
August 2020: diversity and inclusion in clinical trials round-up
The board certification process for healthcare providers should include an appropriate understanding of the clinical relevance of sex-differences in drug treatment. ... Pharmaceutical companies should pay more attention to sex-appropriate dosing,
-
DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
Put simply, underrepresentation of anyone - male or female, old or young, and any ethnicities - means that researchers don’t actually know if the treatment or drug they’re investigating works for
-
WHITE PAPER: Patient nonadherence – the $637bn paradox
To healthcare professionals (HCPs), a patient failing to benefit from drug treatment may require additional consultations, further diagnostic testing, or hospital admission. ... or allied health professionals, who often deliver education, counselling, or
-
Rare Disease Day 2019
Did you know, for example, that over 3.5 million people in the UK suffer from a rare disease or that 95% of rare diseases don't have an approved treatment ... drug and yet they impact more people than cancer and AIDs combined?
-
Big data, privacy and the rise of genomic testing
revolution improves our treatment of disease and gives healthcare professionals greater means to identify the most appropriate treatments, the change is proving to be hugely disruptive. ... This will help inform and progress healthcare from
More from PMHub
Approximately 0 fully matching, plus 10 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Medical Editor
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Account Director
-
Competitive
- New study identifies drugs that are safe to use in COVID-19 treatment
- Celltrion’s investigational mAb cuts COVID-19 recovery time
- J&J trims the size of its phase 3 COVID-19 vaccine trial
- PHE study finds people who have had COVID-19 can still transmit the virus
- AZ’s COVID-19 vaccine trial to continue after Brazilian volunteer death
- COVID-19 vaccine developers respond to new strain
- Live Webinar: COVID-19 Has Changed Live Events Forever!
- New hire and promotions announced at Evoke KYNE
- Amgen strikes $240m autoimmune deal with Evoq Therapeutics
- Lucid Group bolster its talent with a further twelve new starters for 2021
- UK pharmacies to begin administering COVID-19 vaccinations
- PHE study finds people who have had COVID-19 can still transmit the virus
PMHub
Langland
We love what we do and we think it shows.It shows in the work we do, the space we work...
Latest intelligence
- AstraZeneca’s focus on diagnosing and managing chronic kidney disease
- People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
- Delphi Technique Virtual Co-creation: A Customer Story
- How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
- Three ways AI will change healthcare in the next decade
- Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...
Quick links
Infographics
